$1.420
-0.067 (-4.70%)收盤時
CRIS 同業比較
In the context of the broader market, CRIS competes directly with industry leaders such as BCAB and CHGA. With a market capitalization of $4.37M, it holds a leading position in the sector. When comparing efficiency, CRIS's gross margin of N/A stands against BCAB's 100.00% and CHGA's N/A. Such benchmarking helps identify whether Curis Inc is trading at a premium or discount relative to its financial performance.
Curis Inc 財務表現
Curis reported total revenue of $2.93 million in Q3 2024, but faced a net loss of $24.2 million in Q1 2026, reflecting ongoing financial challenges. Despite this, the gross margin was exceptionally high at 104.37% in Q3 2024, indicating strong product profitability when operational issues are resolved.
Financials
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。